Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001362310-07-001714
Filing Date
2007-08-09
Accepted
2007-08-09 14:33:17
Documents
14
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c70974e10vq.htm 10-Q 347018
2 EXHIBIT 4.2 c70974exv4w2.htm EX-4.2 3620
3 EXHIBIT 10.1 c70974exv10w1.htm EX-10.1 87604
4 EXHIBIT 10.3 c70974exv10w3.htm EX-10.3 161342
5 EXHIBIT 10.4 c70974exv10w4.htm EX-10.4 23232
6 EXHIBIT 31.1 c70974exv31w1.htm EX-31.1 8872
7 EXHIBIT 31.2 c70974exv31w2.htm EX-31.2 9177
8 EXHIBIT 32.1 c70974exv32w1.htm EX-32.1 3543
9 EXHIBIT 32.2 c70974exv32w2.htm EX-32.2 3278
10 GRAPHIC c70974c7097401.gif GRAPHIC 132116
11 GRAPHIC c70974c7097402.gif GRAPHIC 92838
12 GRAPHIC c70974c7097403.gif GRAPHIC 17283
13 GRAPHIC c70974c7097404.gif GRAPHIC 88724
14 GRAPHIC c70974c7097405.gif GRAPHIC 21857
  Complete submission text file 0001362310-07-001714.txt   1135964
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 071039595
SIC: 2836 Biological Products, (No Diagnostic Substances)